“…These microbial metabolites can originate both from modifications to host-derived molecules, resulting in the production of branched- and short-chain fatty acids, secondary bile acids, and amino acids derivates such as tryptophan metabolites ( Dai et al, 2011 ; Ridlon et al, 2014 , 2016 ; Morrison and Preston, 2016 ; Liu and Dai, 2020 ), or from de novo synthesis through secondary microbial metabolism (also known as specialized metabolism), which produce a wide range of molecules such as polyketides, non-ribosomal peptides (NRPs), terpenes, NRP synthetase–independent siderophores, and saccharides ( Donia and Fischbach, 2015 ; Postler and Ghosh, 2017 ). Accordingly, a large assortment of small molecules has been isolated from human gut-associated bacteria, highlighting their close involvement in host cellular functions and disease ( Luber and Kostic, 2017 ; Bekkers et al, 2021 ; Tarracchini et al, 2021a ). However, the small molecule repertoire from the human gut microbiota and its evolution from infancy to adulthood have been poorly explored.…”